title: Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types.
abstract: BACKGROUND
  Macrophages play an important role in neuroinflammatory diseases such as multiple sclerosis (MS) and spinal cord injury (SCI), being involved in both damage and repair. The divergent effects of macrophages might be explained by their different activation status: classically activated (CA/M1), pro-inflammatory, macrophages and alternatively activated (AA/M2), growth promoting, macrophages. Little is known about the effect of macrophages with these phenotypes in the central nervous system (CNS) and how they influence pathogenesis. The aim of this study was therefore to determine the characteristics of these phenotypically different macrophages in the context of the CNS in an in vitro setting.
  
  
  RESULTS
  Here we show that bone marrow derived CA and AA macrophages have a distinct migratory capacity towards medium conditioned by various cell types of the CNS. AA macrophages were preferentially attracted by the low weight (< 10 kD) fraction of neuronal conditioned medium, while CA macrophages were attracted in higher numbers by astrocyte- and oligodendrocyte conditioned medium. Intrinsic motility was twice as high in AA macrophages compared to CA macrophages. The adhesion to extracellular matrix molecules (ECM) was significantly enhanced in CA macrophages compared to control and AA macrophages. The actin cytoskeleton was differentially organized between CA and AA macrophages, possibly due to greater activity of the GTPases RhoA and Rac in CA macrophages. Phagocytosis of myelin and neuronal fragments was increased in CA macrophages compared to AA macrophages. The increase in myelin phagocytosis was associated with higher expression of CR3/MAC-1 in CA macrophages.
  
  
  CONCLUSIONS
  In conclusion, since AA macrophages are more motile and are attracted by NCM, they are prone to migrate towards neurons in the CNS. CA macrophages have a lower motility and a stronger adhesion to ECM. In neuroinflammatory diseases the restricted migration and motility of CA macrophages might limit lesion size due to bystander damage.
authors: Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
authors: Elly J F
authors: EJ
authors: Vereyken
authors: Priscilla D A M
authors: PD
authors: Heijnen
authors: Wia
authors: W
authors: Baron
authors: Elga H E
authors: EH
authors: de Vries
authors: Christine D
authors: CD
authors: Dijkstra
authors: Charlotte E
authors: CE
authors: Teunissen
references: J Immunol. 1996 Apr 15;156(8):3017-23
references: 8609424
references: J Leukoc Biol. 2008 Sep;84(3):644-50
references: 18611985
references: J Neurosci. 2004 Mar 3;24(9):2182-90
references: 14999069
references: J Neurosci. 2009 Oct 28;29(43):13435-44
references: 19864556
references: J Interferon Cytokine Res. 1997 Feb;17(2):69-75
references: 9058312
references: Scand J Immunol. 2001 Apr;53(4):386-92
references: 11285119
references: Exp Neurol. 2011 Jul;230(1):3-15
references: 20338167
references: J Leukoc Biol. 2006 Dec;80(6):1298-307
references: 16905575
references: J Immunol. 2001 Dec 1;167(11):6533-44
references: 11714822
references: J Neurosci. 2006 Jan 4;26(1):328-32
references: 16399703
references: Ann Neurol. 1988 Apr;23(4):339-46
references: 3132891
references: Chem Biol Interact. 2006 Mar 25;160(2):123-33
references: 16458870
references: Biochem Pharmacol. 1999 Apr 15;57(8):941-9
references: 10086329
references: Gastroenterology. 2010 Apr;138(4):1395-405
references: 20044996
references: J Neuroimmunol. 1996 Nov;70(2):145-52
references: 8898723
references: J Neurosci. 2007 Oct 3;27(40):10714-21
references: 17913905
references: Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8841-8
references: 10922044
references: J Immunol. 1990 May 15;144(10):3877-80
references: 2332635
references: J Immunol Methods. 1983 Dec 30;65(3):319-32
references: 6655248
references: Brain. 2001 Nov;124(Pt 11):2203-14
references: 11673322
references: Glia. 2000 Feb 15;29(4):366-75
references: 10652446
references: FASEB J. 2001 Aug;15(10):1852-4
references: 11481252
references: Lab Invest. 2009 Jul;89(7):742-59
references: 19398961
references: Mult Scler. 2011 Jan;17(1):2-15
references: 20813772
references: N Engl J Med. 1998 Jan 29;338(5):278-85
references: 9445407
references: Biochem Pharmacol. 1999 Sep 1;58(5):759-65
references: 10449184
references: J Neurosci. 2011 Jan 19;31(3):944-53
references: 21248119
references: Glia. 2001 Sep;35(3):204-12
references: 11494411
references: J Exp Med. 1992 Jul 1;176(1):287-92
references: 1613462
references: J Neuroinflammation. 2006 Sep 27;3:27
references: 17005052
references: Nat Med. 2005 Feb;11(2):146-52
references: 15665833
references: Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):217-21
references: 1729692
references: Exp Neurol. 1997 Dec;148(2):433-43
references: 9417823
references: J Neuropathol Exp Neurol. 1996 Dec;55(12):1194-204
references: 8957442
references: Nat Rev Immunol. 2008 Dec;8(12):958-69
references: 19029990
references: Braz J Med Biol Res. 2002 Mar;35(3):383-9
references: 11887218
references: Cell Immunol. 2000 Aug 25;204(1):19-28
references: 11006014
references: J Exp Med. 2004 Dec 20;200(12):1667-72
references: 15611292
references: Mol Cell Neurosci. 1999 Sep;14(3):199-212
references: 10576890
references: Immunobiology. 1993 Jun;188(1-2):159-71
references: 8104878
references: Hum Immunol. 2009 May;70(5):325-30
references: 19236898
references: Eur J Neurosci. 2004 Aug;20(3):623-34
references: 15255974
references: Eur J Clin Invest. 1990 Oct;20(5):555-62
references: 2124988
references: J Immunol. 2006 Nov 15;177(10):7303-11
references: 17082649
references: Curr Opin Immunol. 2007 Aug;19(4):448-53
references: 17702561
references: Nat Med. 2007 Aug;13(8):935-43
references: 17676050
references: Lab Invest. 2008 Mar;88(3):243-55
references: 18209728
references: Ann Neurol. 2000 Dec;48(6):893-901
references: 11117546
references: Nat Med. 1998 Jul;4(7):814-21
references: 9662373
references: Brain. 2002 Feb;125(Pt 2):338-49
references: 11844734
references: Exp Neurol. 1999 Aug;158(2):351-65
references: 10415142
references: Cytotechnology. 2009 Dec;61(3):125-34
references: 20162352
references: Mult Scler. 1997 Apr;3(2):133-6
references: 9291167
references: Mol Neurobiol. 2007 Oct;36(2):137-51
references: 17952658
references: J Leukoc Biol. 2006 Feb;79(2):285-93
references: 16330536
references: Brain. 2009 Feb;132(Pt 2):465-81
references: 19208690
references: Mol Cell Neurosci. 2005 Feb;28(2):390-401
references: 15691718
references: Arch Neurol. 2003 Aug;60(8):1082-8
references: 12925363
references: Eur J Neurosci. 2000 Jun;12(6):1857-66
references: 10886327
references: J Exp Med. 1990 Oct 1;172(4):1025-33
references: 2145387
references: J Interferon Cytokine Res. 2009 Jun;29(6):313-26
references: 19441883
references: Cell Res. 2010 Apr;20(4):458-69
references: 20142842
references: Neuropathol Appl Neurobiol. 2000 Feb;26(1):2-10
references: 10736062
references: Neurobiol Dis. 2005 Feb;18(1):166-75
references: 15649707
references: Biochem Pharmacol. 2003 Mar 1;65(5):877-85
references: 12628496
references: Immunobiology. 1997 Nov;197(5):478-93
references: 9413747
references: J Exp Med. 1999 Mar 1;189(5):865-70
references: 10049950
references: J Leukoc Biol. 2011 Jan;89(1):93-104
references: 20940325
references: Brain. 2002 Oct;125(Pt 10):2202-12
references: 12244078
references: J Mol Med (Berl). 2009 Mar;87(3):273-86
references: 19050840
references: Annu Rev Physiol. 1982;44:553-68
references: 7041804
references: Eur J Immunol. 1995 Apr;25(4):1101-4
references: 7537672
references: J Neurosci. 2008 Sep 17;28(38):9363-76
references: 18799670
references: J Neuroimmunol. 1998 Dec 1;92(1-2):67-75
references: 9916881
references: Brain. 2002 Jan;125(Pt 1):75-85
references: 11834594
references: Brain Res Brain Res Rev. 2005 Apr;48(2):185-95
references: 15850657
references: J Neuroimmunol. 2002 Jul;128(1-2):49-57
references: 12098510
references: Mol Cell Neurosci. 2006 Jan;31(1):149-60
references: 16297637
references: Brain Res. 2011 May 16;1390:126-41
references: 21406188
references: Brain. 2000 Jun;123 ( Pt 6):1174-83
references: 10825356
references: Nephron Exp Nephrol. 2011;118(4):e87-99
references: 21311199
references: Oncogene. 2010 Apr 29;29(17):2591-8
references: 20140017
references: Lancet Neurol. 2002 Aug;1(4):232-41
references: 12849456
references: J Neuroimmunol. 1998 Apr 15;84(2):238-49
references: 9628469
references: Blood. 2010 Jan 14;115(2):353-62
references: 19880493